(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
Pharmaceutical companies are typically rewarded for their innovation with years of market exclusivity before cheaper generics ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback